Výsledky vyhledávání - Lee, Fa-Chyi
- Zobrazuji výsledky 1 - 11 z 11
-
1
-
2
-
3
-
4
A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers Autor Bauman, Julie, Shaheen, Monte, Verschraegen, Claire F., Belinsky, Steven A., Houman Fekrazad, M., Lee, Fa-Chyi, Rabinowitz, Ian, Ravindranathan, Meera, Jones, Dennie V.
Vydáno 2014Text -
5
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Autor Parikh, Aparna R., Lee, Fa-Chyi, Yau, Linda, Koh, Han, Knost, James, Mitchell, Edith P., Bosanac, Ivan, Choong, Nicholas, Scappaticci, Frank, Mancao, Christoph, Lenz, Heinz-Josef
Vydáno 2019Text -
6
INST OX‐05‐024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial Autor Patt, Yehuda Z., Murad, Waheed, Fekrazad, Mohammed H., Baron, Ari D., Bansal, Pranshu, Boumber, Yanis, Steinberg, Kim, Lee, Sang‐Joon, Bedrick, Ed, Du, Ruofei, Lee, Fa Chyi
Vydáno 2017Text -
7
A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors Autor Sweeney, Christopher J., Chiorean, E. Gabriela, Verschraegen, Claire F., Lee, Fa Chyi, Jones, Suzanne, Royce, Melanie, Tye, Lesley, Liau, Katherine F., Bello, Akintunde, Chao, Richard, Burris, Howard A.
Vydáno 2010Text -
8
Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer Autor Araujo‐Mino, Emilio P., Patt, Yehuda Z., Murray‐Krezan, Cristina, Hanson, Joshua A., Bansal, Pranshu, Liem, Ben J., Rajput, Ashwani, Fekrazad, M. Houman, Heywood, Glenory, Lee, Fa Chyi
Vydáno 2017Text -
9
Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer Autor Shah, Manish A., Wainberg, Zev A., Catenacci, Daniel V. T., Hochster, Howard S., Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C., Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P.
Vydáno 2013Text -
10
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer Autor Shah, Manish A., Wainberg, Zev A., Catenacci, Daniel V. T., Hochster, Howard S., Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C., Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P.
Vydáno 2021Text -
11
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre,... Autor Lu, Zhihao, Wang, Junye, Shu, Yongqian, Liu, Lianke, Kong, Li, Yang, Lei, Wang, Buhai, Sun, Guogui, Ji, Yinghua, Cao, Guochun, Liu, Hu, Cui, Tongjian, Li, Na, Qiu, Wensheng, Li, Gaofeng, Hou, Xinfang, Luo, Hui, Xue, Liying, Zhang, Yanqiao, Yue, Wenbin, Liu, Zheng, Wang, Xiuwen, Gao, Shegan, Pan, Yueyin, Galais, Marie-Pierre, Zaanan, Aziz, Ma, Zhuo, Li, Haoyu, Wang, Yan, Shen, Lin, Pan, Zhanyu, Zhang, Shuqun, Lin, Gen, Xie, Yanru, Li, Tao, Ren, Tiejun, Li, Weidong, Gu, Kangsheng, Wang, Shoufeng, He, Wei, Xia, Bing, Fan, Yun, Liang, Jun, Zhao, Kuaile, Pan, Hongming, Xu, Nong, Cheng, Ying, Gao, Quanli, Sun, Ping, Zang, Aimin, Zheng, Anping, Luo, Zhiguo, Liu, Tianshu, Ding, Shubo, Xu, Tianwen, Li, Wei, Liu, Fang, Cang, Shundong, Wang, Junsheng, Lin, Xiaoyan, Jiang, Da, Mao, Rui, Ma, Dong, Liu, Yunpeng, Tao, Min, Tang, Yong, Chen, Xi, Chen, Ping, Feng, Guosheng, Yang, Zhenzhou, Zhang, Guifang, Zhang, Xuebang, Huang, Yong, Lee, Fa-Chyi, Dean, Andrew, El Hajbi, Farid, Ghiringhelli, François, Borg, Christophe, Tougeron, David, Dahan, Laetitia, Pernot, Simon, Rivera, Fernando, Pazo Cid, Roberto Antonio, Vazquez Rivera, Maria Francisca
Vydáno 2022Text